Nov. 6, 2003 — The first large-scale randomized trial of cannabis for treatment of symptoms of multiple sclerosis, reported in the Nov. 8 issue of The Lancet, had mixed results. The objective measure ...
Researchers funded by the UK Medical Research Council (MRC) have found mixed evidence about the value of cannabis-derived treatments for people with Multiple Sclerosis (MS) but conclude that such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback